Neuronetics (STIM) Cash & Current Investments (2016 - 2026)

Neuronetics (STIM) has 11 years of Cash & Current Investments data on file, last reported at $13.5 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $13.5 million, down 36.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (down 36.53% YoY), and the FY2025 annual result was $6.2 million, up 416.17% from the prior year.
• Cash & Current Investments rose to $13.5 million in Q1 2026 per STIM's latest filing, from $6.2 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $82.9 million in Q1 2022 and troughed at $1.2 million in Q4 2024.
• A 5-year average of $40.9 million and a median of $43.3 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 98.01% in 2024, then soared 416.17% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $71.9 million in 2022, then dropped by 15.72% to $60.6 million in 2023, then plunged by 98.01% to $1.2 million in 2024, then soared by 416.17% to $6.2 million in 2025, then soared by 116.4% to $13.5 million in 2026.
• Business Quant data shows STIM's Cash & Current Investments at $13.5 million in Q1 2026, $6.2 million in Q4 2025, and $28.1 million in Q3 2025.